T1	Condition 0 21	Anaphylactic reaction
T2	Temporal 27 35	previous
T3	Drug 44 61	influenza vaccine
T4	Drug 75 89	its components
*	OR T3 T4
T5	Scope 44 89	influenza vaccine or to any of its components
R1	Has_temporal Arg1:T5 Arg2:T2	
R2	Has_scope Arg1:T1 Arg2:T5	
T6	Condition 97 145	Immunoglobulin E (IgE)-mediated hypersensitivity
T7	Drug 149 153	eggs
T8	Condition 168 173	hives
T9	Condition 175 196	swelling of the mouth
T10	Condition 175 190;201 207	swelling of the throat
T11	Condition 209 232	difficulty in breathing
T12	Condition 234 245	hypotension
T13	Condition 250 255	shock
*	OR T13 T12 T11 T10 T9 T8
T14	Scope 168 255	hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock
R3	AND Arg1:T6 Arg2:T7	
R4	Has_scope Arg1:T6 Arg2:T14	
T15	Condition 257 281	Guillain- Barr√© syndrome
T16	Temporal 282 332	within eight weeks of a previous influenza vaccine
T17	Reference_point 304 332	a previous influenza vaccine
T18	Temporal 306 314	previous
T19	Drug 315 332	influenza vaccine
R5	Has_temporal Arg1:T19 Arg2:T18	
R6	multi Arg1:T17 Arg2:T19	
R7	Has_index Arg1:T16 Arg2:T17	
R8	Has_temporal Arg1:T15 Arg2:T16	
T20	Drug 341 348	aspirin
T21	Drug 352 383	salicylate- containing products
T22	Temporal 384 416	within 30 days before enrollment
*	OR T20 T21
T23	Scope 341 383	aspirin or salicylate- containing products
R9	Has_temporal Arg1:T23 Arg2:T22	
T24	Person 418 435	Household members
T25	Person 439 447	children
T26	Person 451 458	Group A
T27	Scope 439 458	children in Group A
R10	Has_scope Arg1:T24 Arg2:T27	
